Average Co-Inventor Count = 6.86
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (26 from 1,974 patents)
2. Immatics Biotechnologies Gmbh (1 from 725 patents)
3. Amgen Research (munich) Gmbh (1 from 75 patents)
26 patents:
1. 12331122 - Anti-ASGR-1 monoclonal inhibitory antibodies
2. 12312412 - MAGEB2 binding constructs
3. 12012449 - Human IL-23 antigen binding proteins
4. 11891435 - Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
5. 11248043 - Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof
6. 10738110 - PAC1 antibodies and uses thereof
7. 9994923 - Neutralizing proprotein convertase subtilisin kexin type 9 (PCSK9) variants and uses thereof
8. 9951129 - Human IL-23 antigen binding proteins
9. 9920134 - Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)
10. 9493576 - Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
11. 9487580 - Human IL-23 antigen binding proteins
12. 9056915 - Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
13. 9045547 - Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
14. 8889834 - Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
15. 8883983 - Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)